Cancer cells have a remarkable ability to survive treatments that damage their DNA. One reason is that they rely on sophisticated repair systems that can fix genetic damage that would otherwise kill them. Among the most important of these systems is homologous recombination, a highly accurate DNA repair process that depends on proteins such as RAD51 and CHK1.
Cancer therapies known as PARP inhibitors were designed to exploit weaknesses in DNA repair. While the...

1 week ago
21








English (US) ·